Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia
NCT: NCT07226648 · RECRUITING
Brief Summary
The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time points throughout the 16-week study.
Frequently Asked Questions
What is Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia?
Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia is a clinical trial registered under NCT07226648. Current status: RECRUITING.
What is the status of NCT07226648?
The current status of NCT07226648 (Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia) is: RECRUITING.
When did Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia start?
Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia started on 2025-12-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.